Eledon Pharmaceuticals To Present Updated Data From Ongoing Phase 1B Trial Of Tegoprubart In Patients Undergoing Kidney Transplantation At The American Transplant Congress

Press/Media

Period9 May 2024

Media coverage

94

Media coverage